Bluejay Diagnostics (BJDX) Change in Account Payables (2020 - 2026)
Bluejay Diagnostics' (BJDX) quarterly Change in Account Payables came in at $6033.0 in Q1 2026, down 98.39% year-on-year from $374402.0 in Q1 2025, and down 88.64% quarter-over-quarter from $53093.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Change in Account Payables (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has disclosed Change in Account Payables across 7 years of filings, most recently posting $6033.0 for Q1 2026.
- Change in Account Payables for Q1 2026 came in at $6033.0, down 98.39% year-over-year; the trailing twelve-month figure through Mar 2026 was -$299236.0 (down 220.81% YoY), and the FY2025 annual result was $69133.0, up 119.96% from the prior year.
- Change in Account Payables came in at $6033.0 for Q1 2026 at Bluejay Diagnostics, down from $53093.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $448199.0 in Q3 2023 to a low of -$520728.0 in Q2 2022.
- The 5-year median for Change in Account Payables is $6033.0 (2026), against an average of -$12239.1.
- Peak annual rise in Change in Account Payables reached 6377.12% in 2022, while the deepest fall reached 789.36% in 2022.
- Bluejay Diagnostics' Change in Account Payables stood at $379948.0 in 2022, then sank by 166.95% to -$254369.0 in 2023, then jumped by 32.57% to -$171528.0 in 2024, then surged by 130.95% to $53093.0 in 2025, then slumped by 88.64% to $6033.0 in 2026.
- The last three Change in Account Payables figures came in at $6033.0 (Q1 2026), $53093.0 (Q4 2025), and $52345.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Bluejay Diagnostics | 4.43 Mn | 746,549.00 | - | 6,033.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,033.00 |
| Mar 31, 2026 | 6,033.00 |
| Dec 31, 2025 | 53,093.00 |
| Dec 31, 2025 | 53,093.00 |
| Sep 30, 2025 | 52,345.00 |
| Sep 30, 2025 | 52,345.00 |
| Jun 30, 2025 | -410,707.00 |
| Jun 30, 2025 | -410,707.00 |
| Mar 31, 2025 | 374,402.00 |
| Mar 31, 2025 | 374,402.00 |
| Dec 31, 2024 | -171,528.00 |
| Dec 31, 2024 | -171,528.00 |
| Sep 30, 2024 | -173,406.00 |
| Sep 30, 2024 | -173,406.00 |
| Jun 30, 2024 | 218,231.00 |
| Jun 30, 2024 | 218,231.00 |
| Mar 31, 2024 | -219,649.00 |
| Mar 31, 2024 | -219,649.00 |
| Dec 31, 2023 | -254,369.00 |
| Dec 31, 2023 | -254,369.00 |